← back to search

Toby Garrood

Guy's and St Thomas' NHS Foundation Trust ·
Area of research
Rheumatology · Psychiatry and Mental health
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Fibromyalgia and Chronic Fatigue Syndrome Research, and Autoimmune and Inflammatory Disorders Research.
h-index
19
citations
1,796
works
78
NIH funding
primary concept
email

Recent publications

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
The Lancet 2024cited by 156position: middledoi
Pain Reduction With Oral Methotrexate in Knee Osteoarthritis
Annals of Internal Medicine 2024cited by 31position: middledoi
The Clinical Impact of Electronic <scp>Patient‐Reported</scp> Outcome Measures in the Remote Monitoring of Inflammatory Arthritis: A Systematic Review and Meta‐analysis
Arthritis & Rheumatology 2023cited by 34position: lastdoi
Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis
BMC Rheumatology 2019cited by 35position: middledoi
Persistent physical symptoms reduction intervention: a system change and evaluation in secondary care (PRINCE secondary) – a CBT-based transdiagnostic approach: study protocol for a randomised controlled trial
BMC Psychiatry 2019cited by 30position: middledoi
Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis
Annals of Internal Medicine 2018cited by 90position: middledoi
Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes
The Journal of Rheumatology 2018cited by 65position: middledoi
The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life
Seminars in Arthritis and Rheumatism 2018cited by 35position: middledoi
Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis
Lara D. Veeken 2016cited by 45position: middledoi
Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial
Trials 2015cited by 42position: middledoi
Interleukin‐17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
Arthritis & Rheumatology 2014cited by 286position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David L. Scott · Monash University6 papers (2015–2024)Bruce Kirkham · St Thomas' Hospital4 papers (2014–2019)Nigel Arden · Nuffield Orthopaedic Centre3 papers (2015–2024)Fraser Birrell · Newcastle University3 papers (2015–2024)Fiona E. Watt · Imperial College Healthcare NHS Trust3 papers (2015–2024)Puvan Tharmanathan · University of York3 papers (2015–2024)Philip G. Conaghan · Nonwovens Innovation & Research Institute3 papers (2015–2024)David Torgerson · York University3 papers (2015–2024) · 3 papers (2016–2019)G S Panayi · Guy's Hospital3 papers (2016–2019)Andrew P. Cope · King's College London3 papers (2018–2019)Terence W O’Neill · NIHR Oxford Musculoskeletal Biomedical Research Centre3 papers (2015–2024)Sarah R. Kingsbury · University of Glasgow3 papers (2015–2024)Michael Doherty · Nottingham Biomedical Research Centre3 papers (2015–2024)Nicola Gullick · University Hospital Coventry2 papers (2014–2019)Edward Roddy · Indiana University School of Medicine2 papers (2015–2024)Sarah Ronaldson · University of York2 papers (2018–2024)Catherine Arundel · University of Manchester2 papers (2018–2024)Andrew J. Grainger · University of Cambridge2 papers (2015–2018)Robert J. Moots · Edge Hill University2 papers (2015–2024)